Peritumoral Delivery of Docetaxel‐TIPS Microparticles for Prostate Cancer Adjuvant Therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Peritumoral Delivery of Docetaxel‐TIPS Microparticles for Prostate Cancer Adjuvant Therapy ; year:2020
Advanced therapeutics ; (2020)
- Urheber
-
Paliashvili, Ketevan
Popov, Alexander
Kalber, Tammy L.
Patrick, P. Stephen
Hayes, Angela
Henley, Alan
Raynaud, Florence I.
Ahmed, Hashim U.
Day, Richard M.
- DOI
-
10.1002/adtp.202000179
- URN
-
urn:nbn:de:101:1-2021020407431142970606
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Paliashvili, Ketevan
- Popov, Alexander
- Kalber, Tammy L.
- Patrick, P. Stephen
- Hayes, Angela
- Henley, Alan
- Raynaud, Florence I.
- Ahmed, Hashim U.
- Day, Richard M.
Ähnliche Objekte (12)
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
Perspectives in Adjuvant Treatment of Prostate Cancer
Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis
Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
Perspectives in Adjuvant Treatment of Prostate Cancer
Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis
Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
Perspectives in Adjuvant Treatment of Prostate Cancer
Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis
Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer